186 related articles for article (PubMed ID: 32882089)
1. The association between systolic blood pressure reduction during clonidine suppression testing and the decrease in plasma catecholamines and metanephrines.
Golani T; Fishman B; Sharabi Y; Olswang-Kutz Y; Leibowitz A; Grossman E; Shlomai G
J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1924-1931. PubMed ID: 32882089
[TBL] [Abstract][Full Text] [Related]
2. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
[TBL] [Abstract][Full Text] [Related]
3. A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma.
Lee GR; Johnston PC; Atkinson AB; McKillop D; Auld P; Hunter SJ
J Hypertens; 2011 Dec; 29(12):2422-8. PubMed ID: 22002333
[TBL] [Abstract][Full Text] [Related]
4. Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
Remde H; Pamporaki C; Quinkler M; Nölting S; Prejbisz A; Timmers HJLM; Masjkur J; Fuss CT; Fassnacht M; Eisenhofer G; Deutschbein T
Hypertension; 2022 Jun; 79(6):1257-1264. PubMed ID: 35378989
[TBL] [Abstract][Full Text] [Related]
5. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
Goupil R; Fountoulakis S; Gordon RD; Stowasser M
J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
[TBL] [Abstract][Full Text] [Related]
6. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
8. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
9. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
[TBL] [Abstract][Full Text] [Related]
10. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
[TBL] [Abstract][Full Text] [Related]
11. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
[TBL] [Abstract][Full Text] [Related]
12. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
13. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
[TBL] [Abstract][Full Text] [Related]
14. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
Därr R; Lenders JW; Stange K; Kindel B; Hofbauer LC; Bornstein SR; Eisenhofer G
Dtsch Med Wochenschr; 2013 Jan; 138(3):76-81. PubMed ID: 23299341
[TBL] [Abstract][Full Text] [Related]
16. Plasma metanephrines in the diagnosis of pheochromocytoma.
Lenders JW; Keiser HR; Goldstein DS; Willemsen JJ; Friberg P; Jacobs MC; Kloppenborg PW; Thien T; Eisenhofer G
Ann Intern Med; 1995 Jul; 123(2):101-9. PubMed ID: 7778821
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
van Berkel A; Lenders JW; Timmers HJ
Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
[TBL] [Abstract][Full Text] [Related]
19. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
[TBL] [Abstract][Full Text] [Related]
20. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.
Sawka AM; Jaeschke R; Singh RJ; Young WF
J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
